79301735
Aug 27, 2020
May 11, 2021
FRESENIUS KABI DEUTSCHLAND GMBH
Active Trademark
Pharmaceutical preparations for human use for the treatment of neurological diseases and disorders, immunological diseases and disorders, inflammatory diseases and disorders, oncological diseases and disorders and viral infections, as well as treatment of CAR T-cell induced cytokine release syndrome
Pharmaceuticals